World Courant
PIEX Group, a number one distributor of healthcare and wellness merchandise in Africa, proclaims that it has signed the acquisition of Apexfarma Group, an organization specialised within the improvement and promotion of pharmaceutical merchandise in each Africa and North Asia.
This acquisition will allow PIEX Group to proceed its dynamic path of enlargement throughout the African continent and supply its healthcare companions the prospect of exponential development in these numerous and strong markets. Apexfarma’s complementary platform will supply and help that of PIEX Group
strategic goal to satisfy the continent’s unprecedented demand and supply entry to high quality healthcare merchandise
for everybody. The transaction additionally contains the acquisition of Cross Pharm Laboratory, a subsidiary of the
Apexfarma Group.
PIEX Group, based in 1979, relies in France and has greater than 50 workers. By its essential shareholder LBO France and others – Africinvest and Bpifrance, the group has forecast a turnover of greater than €144 million in 2022 (a rise of 6% in comparison with 2021), making the group one of the financially steady corporations within the healthcare ecosystem in Africa.
Based by Carlos Pijoan in 1995, Apexfarma relies in Barcelona, Spain and covers greater than 40 markets, together with most of Sub-Saharan Africa.
The corporate has a gross sales, advertising and marketing and regulatory workforce of roughly 350 workers, based mostly in respective markets in Africa, and is predicted to develop quickly to greater than 500 by the tip of 2024. The administration workforce of 18 folks coordinates the strategic capabilities managed by energetic promotion, greater than 50 manufacturers and greater than 900 regulatory recordsdata. Yearly, the sphere groups make greater than 700,000 visits to docs and pharmacists.
The enlargement of PIEX Group in Africa
Since its inception, PIEX Group has relied on a community of companions to make sure its shut proximity
potential to the sphere and that its provide is protected. For greater than 20 years, PIEX Group and Apexfarma have labored collectively to convey high quality medicines to sufferers in Africa and to strengthen strategic
product entry ambitions of their key associate laboratories.
The French-speaking African market has historically been characterised by the separation of the worth chain
capabilities similar to pharmaceutical distribution and pharmaceutical promotions, which makes administration capabilities advanced in an atmosphere that’s generally unstable and fragmented. The alliance between PIEX Group and Apexfarma will complement and revolutionize the worth chain by offering our associate laboratories with a single platform.
The providing, which integrates regulation, advertising and marketing/market evaluation and gross sales, in addition to logistics and distribution, will increase its impression on the continent. Above all, this alliance will make it potential to broaden entry to high quality medicines to as many individuals as potential, towards the backdrop of hovering demand and a resurgence of counterfeit medicines.
In the direction of worth chain integration
The acquisition of Apexfarma and subsidiary Cross Pharm additionally permits PIEX Group to broaden its actions
larger up the worth chain. With Cross Pharm, PIEX Group turns into a advertising and marketing authorization holder (MA)
and the fitting to use emblems. Issuing these advertising and marketing authorizations is a protracted and sophisticated course of
will give PIEX Group management over an essential section within the worth chain. In the end, the Group will develop an R&D
platform centered on ailments and wishes particular to Africa, that are more and more uncared for
conventional gamers within the pharmaceutical trade.
Bertrand Talbotier, Chairman of PIEX Group, stated: “This acquisition illustrates the sturdy development momentum of PIEX Group, due to the help of its shareholders and towards a backdrop of quickly rising demand for medicines on the African continent. It offers us the instruments to satisfy the challenges of the African healthcare market within the coming many years. The Group is on a gentle development path.”
Jean-Marie Leroy, Companion liable for the Small Cap exercise at LBO France, feedback: “By this alliance with Apexfarma, PIEX Group takes a brand new step in its improvement and provides itself the means to change into the main distributor of well being and well-being merchandise. change into. merchandise are in Africa. Supported by LBO France’s operational groups, PIEX Group is pursuing an bold ESG technique to advertise entry to medicines for all, in a area with very excessive development potential.”
Carlos Pijoan, CEO of Apexfarma, stated: “This alliance with PIEX Group is a pure one. For greater than 20 years, we have now been constructing long-term partnerships that assure reliability and belief on a posh continent. Because the founding father of the group, I’m assured that the PIEX Group groups will take Apexfarma and Cross Pharm to the subsequent section of their historical past.”
About PIEX Group
PIEX Group is a distributor of well being and wellness merchandise, primarily energetic in Africa. With a catalog of greater than
With greater than 2,000 merchandise, PIEX Group maintains a privileged hyperlink between upstream producers and downstream producers
gamers within the provide chain: wholesalers, pharmacies and hospitals. PIEX is a very unbiased firm
firm on the service of its clients, suppliers and shareholders.
With its built-in providing, PIEX Group presents a ‘one-stop-shop’ answer for the African well being and wellness market. The Group is a part of a broader challenge to develop an “worldwide firm centered on Africa”, with the goal of offering high quality well being and wellness services to as many individuals as potential, at prices tailored to the constraints of the market.
About Apexfarma
Apexfarma presents the pharmaceutical trade an built-in answer for exporting healthcare merchandise, primarily to Africa, but in addition to CIS international locations and Jap Europe.
Apexfarma’s mission is to supply drug producers with a dependable, skilled and environment friendly answer
for entry to rising markets.
PIEX Group completes the acquisition of the Apexfarma group and its subsidiary Cross Pharm
Africa Area Information ,Subsequent Large Factor in Public Knowledg
